Skip to main content
Equibles

Yiheng Capital Management, L.P.

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1447228 SAN FRANCISCO, CA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,356,523
+$3,273,667 QoQ
Shares Held
400,464
+91.9% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
3.24%
of 13F equity value
Holder Rank
#52
of 215 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Yiheng Capital Management, L.P. holds $18,566,712 across 5 Biotechnology names. VRDN ranks #1 (39.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRDN
Viridian Therapeutics, Inc.\DE
This page 		400,464 $7,356,523
2 KYMR
Kymera Therapeutics, Inc.
 63,440 $7,274,664
3 DBVT
DBV Technologies S.A.
 170,142 $2,790,328
4 BEAM
Beam Therapeutics Inc.
 21,126 $725,044
5 PASG
Passage BIO, Inc.
 86,097 $420,153

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,356,523 400,464
2026-03-31 $4,082,856 208,735
2025-12-31 $6,495,833 208,735
2025-09-30 $10,795,632 500,261
2025-06-30 $6,993,648 500,261
2025-03-31 $6,743,518 500,261
2024-12-31 $14,382,503 750,261
2024-09-30 $19,289,520 847,891
2024-06-30 $12,335,171 948,130
2024-03-31 $16,601,756 948,130
2023-12-31 $26,757,470 1,228,534
2023-09-30 $18,845,711 1,228,534
2023-06-30 $29,226,823 1,228,534
2023-03-31 $31,253,904 1,228,534
2022-12-31 $28,136,707 963,256
2022-09-30 $7,651,276 373,051